Sign-in

User Name

Password

Remember Me

Forgot your password?

Forgot your username?

Create an account

Home
Community
Knowledge Hub
Hot Topics
Conference
- 2023
- 2020
- 2017
- 2015

The Knowledge Hub for immunization professionals

Browse thousands of immunization resources shared by TechNet members

Filter:

Start discussion

Related resources

*Meeting Summary: Global Vaccine and Immunization Research Forum, 2021

*Meeting Summary: Global Vaccine and Immunization Research Forum, 2021

Agenda - GVIRF 2021

W8.1 Decision-making and prioritization of vaccines to address public health needs in LMICs

W1.2 Vaccine Manufacturing at Lab Scale: A paradigm shift to more affordable vaccines

W5.3 Single-dose HPV Vaccination

W8.3 The State of Play: Industry vaccine trends from the Access to Medicine Index

KN2.2 Innovating from Research to Impact at Scale: the role of the Gavi Alliance

W9.3 Building and Sustaining Uptake: Case study the Philippines

W8.2 Prioritization of Vaccines for Global Health

P1.3 Rapid (and precise) COVID-19 Vaccine Development Enabled by Prototype Pathogen Preparedness

W3.2 Transformative Concepts for Mass Vaccination and Pandemic Response

W2.2 Viral vectored vaccine platform technologies

W9.2 Evidence and Lessons Learned on Social Sciences Analytics around Vaccination

W6.1 Vaccine Development to Access: Opportunities, risks and potential valleys of death

KN1 Vaccinology in the context of pandemic preparedness: The COVID-19 experience

W4.2 Typhoid controlled human infection model

W6.3 Building the concept of WHO Vaccine Preferred Policy Profiles

W1.3 Not enough to go around: vaccine manufacturing for the COVID-19 pandemic

W2.1 Nucleic acid vaccines: Is it all done?

W3.3 Considerations for mass deployment of innovative vaccines in low- and middle-income country immunization programs

W2.4 Universal Influenza Vaccines

P2.1 Current status and future prospects for human immunodeficiency virus (HIV) vaccines

P1.2 Rapid Response Platforms for COVID-19 Vaccine

W4.1 Controlled human malaria infection — tool for accelerating vaccine development

W5.2 Schistosomiasis vaccines, development and role in elimination

P3.2 Impact of COVID-19 on coverage and equity

W5.1 Salmonella typhi vaccines, development and deployment

W6.2 Vaccine development to access: Is there a role for earlier policy consideration?

W7.1 Protection of newborn infants through vaccination

KN1 Vaccinology in the context of pandemic preparedness: The COVID-19 experience

KN1 Vaccinology in the context of pandemic preparedness: The COVID-19 experience

KN1 Vaccinology in the context of pandemic preparedness: The COVID-19 experience

Agenda - GVIRF 2021

W3 Innovation in Vaccination

W9 Building and Sustaining Uptake

W4 Controlled Human Infection Models for Vaccine Research and Development

P2 HIV, TB & Malaria Vaccine Update

P2 HIV, TB & Malaria Vaccine Update

P2 HIV, TB & Malaria Vaccine Update

P2.2 Update on progress in tuberculosis vaccine development

W5 New and Improved Vaccines on the Horizon

W9.1 Building and Sustaining Uptake: Summary of the latest evidence and open research questions

W2.3 Adjuvants for use in subunit-based vaccines and global access focus on licensed one

W5.4 Improved vaccines: Novel oral polio vaccine (OPV)

P1.1 Research during outbreak response: from Ebola to the COVID-19 pandemic

P1 Epidemic and Pandemic Preparedness and Response

W1 Innovations in Vaccine Manufacturing

KN3 Research for Equity - VIDEO

KN3 Research for Equity

P3.1 The enduring dilemma of 20 million unvaccinated children: Equity and access solutions in IA2030

Introduction to GVIRF

W8 Prioritization for Vaccine R&D

P3 Shaping the Future: Equitable Access for All

KN2 The Lessons of COVID-19 for Vaccine Development

W2 Emerging Platforms

W6 Vaccine Development to Access

W2.3 Adjuvants

Adjuvants for use in subunit based vaccines and their global access considerations.

Author

Nathalie Garcon

Publication year

2021

Language

Type

Category

Global initiatives

Diseases

Related reference code

Organisation

Global Vaccine Action Plan (GVAP)

Added by: Angela Hwang
Added on: 22 June, 2021
Hits: 699

Only logged in users are allowed to add feedback.

Edit resource

1 .Selecting a type
2 .Select a Category
3-
4-

Type *

Category *

Vaccines & delivery devices

Supply chain & logistics

Service delivery

Data

Programme management

Global initiatives

Title *

Description *

Author *

Language *

Country

Organisation

Thumbnail

Resource upload

Link

Publication year

Publisher

Related Resource Reference

Tags

30DTR

AEFI

Anti-vax

App

Barcode

BCG

Biometrics

Campaign

CCEOP

Cloud

CMYP

Cold box / vaccine carrier

Cold room / freezer room

Communications

Disease

Cholera

Covid-19

Dengue

Diphtheria

Ebola

Haemophilus influenzae

Hepatitis A

Hepatitis B

Hepatitis E

HIB

HIV-AIDS

HPV

Influenza

Japanese encephalitis

WHO Region

PubMed URL

Journal

Volume

Issue

Subnational area (if relevant)

Year of introduction (approximate)

Remit

Maternal health: Does the HBR include maternal health recording info?

Childhood vaccination information is recorded?

Childhood growth monitoring information is recorded?

Newborn health information is recorded?

CRVS-related information is recorded?

Other child survival information is recorded?

Child health information beyond first year is recorded?

Size

Format

Update resource

Resource updated successfully

You have successfully updated a resource

View resource

Back to library

Established by WHO and UNICEF in 1989, we are a global network of immunization professionals committed to strengthening immunization services

Home
About Us
Mission
Partners
History
Contact
Terms

Knowledge Hub
Vaccines & Devices
Supply chain
Service delivery
Data
Programme management
Global initiatives

Community
Dashboard
Forum
Events
Careers
Blogs

More
Diseases
Organisations
Hot Topics

© TechNet-21.org 2022. All right reserved.
Terms and Conditions
Privacy Policy